No results for ‘’
Vista Pharmaceuticals Ltd
₹5.75
(1.03%)
Fri, 18 Sept 2026, 09:44 am
Vista Pharmaceuticals Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 21.19 | 21.19 | 21.19 | 21.19 | 21.19 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Public | 78.79 | 78.79 | 78.79 | 78.79 | 78.79 |
| Government | 0 | 0 | 0 | 0 | 0 |
Vista Pharmaceuticals Ltd Shareholding Pattern
The Vista Pharmaceuticals Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Vista Pharmaceuticals Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Vista Pharmaceuticals Ltd (NSE: , BSE: 524711) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Vista Pharmaceuticals Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Vista Pharmaceuticals Ltd Shareholding Pattern (Latest)
The latest Vista Pharmaceuticals Ltd shareholding for Mar 2026 is:
- Promoters: 21.19%
- FII: 0%
- DII: 0.02%
- Public: 78.79%
- Government: 0%
Promoter holding in Vista Pharmaceuticals Ltd remains stable, reflecting consistent long-term commitment.
Vista Pharmaceuticals Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Vista Pharmaceuticals Ltd.
- Mar 2026: 21.19%
- Dec 2025: 21.19%
- Sept 2025: 21.19%
- Jun 2025: 21.19%
- Mar 2025: 21.19%
Promoter stake remains largely stable, showing consistent ownership structure.
Vista Pharmaceuticals Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Vista Pharmaceuticals Ltd.
- Mar 2026: 0%
- Dec 2025: 0%
- Sept 2025: 0%
- Jun 2025: 0%
- Mar 2025: 0%
FII holding has declined, suggesting cautious sentiment among foreign investors.
Vista Pharmaceuticals Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 0.02%
- Dec 2025: 0.02%
- Sept 2025: 0.02%
- Jun 2025: 0.02%
- Mar 2025: 0.02%
DII holdings remain stable, reflecting steady institutional participation.
Vista Pharmaceuticals Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 78.79%
- Dec 2025: 78.79%
- Sept 2025: 78.79%
- Jun 2025: 78.79%
- Mar 2025: 78.79%
Public holding remains stable with consistent retail participation.
Vista Pharmaceuticals Ltd Government Holding
Government holding in Vista Pharmaceuticals Ltd currently stands at 0%.
Vista Pharmaceuticals Ltd operates without significant government ownership.
Vista Pharmaceuticals Ltd Shareholding Analysis Summary
The Vista Pharmaceuticals Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Investors should monitor changes in Vista Pharmaceuticals Ltd shareholding for signals on institutional sentiment and ownership trends.
Regular monitoring of the Vista Pharmaceuticals Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.